Lv01
0 积分 2025-07-30 加入
KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema
2小时前
已完结
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment
2小时前
已关闭
Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment
12小时前
已关闭
Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
12小时前
已完结
皖公网安备34019202002308
